Company: GANX
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001104659-25-110347
Chunk: 4

Company: Gain Therapeutics, Inc.
Filing Date: 2025-11-12
Form: 10-Q
Item: Part I, Item 1F
Chunk 4
---
Item 1. Condensed Consolidated Financial Statements.

​

PART I—FINANCIAL INFORMATION

​

GAIN THERAPEUTICS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

​​​​​​​​ ​        September 30,     December 31, ​​​2025​2024Assets  ​   ​  Current assets:  ​   ​  Cash and cash equivalents ​$ 8,807,353​$ 10,385,863Tax credits​​​ 271,515​​ 271,079Prepaid expenses and other current assets ​  1,438,400​  945,536Total current assets ​​ 10,517,268​​ 11,602,478​​​​​​​​Noncurrent assets: ​   ​   Property and equipment, net ​  85,572​  103,619Internal-use software, net​​​ 114,607​​ 134,268Operating lease right-of-use assets ​  184,422​  219,715Restricted cash ​  36,117​  31,695Long-term deposits and other noncurrent assets ​  33,694​  32,109Total noncurrent assets ​​ 454,412​​ 521,406Total assets ​$ 10,971,680​$ 12,123,884​​​​​​​​Liabilities and stockholders' equity​​​​​​​Current liabilities: ​   ​   Accounts payable ​$ 1,577,151​$ 946,259Operating lease liability - current ​  115,910​  160,913Other current liabilities ​  2,340,703​  2,441,761Deferred grant income - current ​  11,293​  252,211Loans - current ​​ 125,545​​ 110,177Total current liabilities ​​ 4,170,602​​ 3,911,321​​​​​​​​Noncurrent liabilities: ​   ​   Defined benefit pension plan ​​ 527,825​​ 443,623Operating lease liability - noncurrent ​  65,026​  53,598Deferred grant income - noncurrent​​​ —​​ 47,441Loans - noncurrent ​​ 298,797​​